These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 27117514)
1. Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics. Cha MK; Kang CI; Kim SH; Cho SY; Ha YE; Chung DR; Peck KR; Song JH Diagn Microbiol Infect Dis; 2016 Jun; 85(2):210-2. PubMed ID: 27117514 [TBL] [Abstract][Full Text] [Related]
2. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms. Jia W; Wang J; Xu H; Li G Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315 [TBL] [Abstract][Full Text] [Related]
3. Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Shimizu K; Kikuchi K; Sasaki T; Takahashi N; Ohtsuka M; Ono Y; Hiramatsu K Antimicrob Agents Chemother; 2008 Oct; 52(10):3823-5. PubMed ID: 18644963 [TBL] [Abstract][Full Text] [Related]
4. [Investigating the fluoroquinolone molecular resistant mechanism of Stenotrophomonas maltophilia]. Tao CM; Lü XJ; Li P Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):266-9. PubMed ID: 16608091 [TBL] [Abstract][Full Text] [Related]
5. Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Ribera A; Doménech-Sanchez A; Ruiz J; Benedi VJ; Jimenez de Anta MT; Vila J Microb Drug Resist; 2002; 8(4):245-51. PubMed ID: 12523620 [TBL] [Abstract][Full Text] [Related]
6. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital. Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital. Pien CJ; Kuo HY; Chang SW; Chen PR; Yeh HW; Liu CC; Liou ML J Microbiol Immunol Infect; 2015 Jun; 48(3):291-5. PubMed ID: 24239064 [TBL] [Abstract][Full Text] [Related]
8. Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States. Mojica MF; Rutter JD; Taracila M; Abriata LA; Fouts DE; Papp-Wallace KM; Walsh TJ; LiPuma JJ; Vila AJ; Bonomo RA mBio; 2019 Jul; 10(4):. PubMed ID: 31266860 [No Abstract] [Full Text] [Related]
9. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients. Sahasrabhojane P; Galloway-Peña J; Velazquez L; Saldaña M; Horstmann N; Tarrand J; Shelburne SA Int J Antimicrob Agents; 2014 Jun; 43(6):558-62. PubMed ID: 24721231 [TBL] [Abstract][Full Text] [Related]
10. Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Gülmez D; Hasçelik G Clin Microbiol Infect; 2005 Nov; 11(11):880-6. PubMed ID: 16216102 [TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital. Duan Z; Qin J; Liu Y; Li C; Ying C BMC Microbiol; 2020 Sep; 20(1):294. PubMed ID: 32993493 [TBL] [Abstract][Full Text] [Related]
13. Stenotrophomonas maltophilia in a university hospital of traditional Chinese medicine: molecular epidemiology and antimicrobial resistance. Zhao S; Yang L; Liu H; Gao F J Hosp Infect; 2017 Jul; 96(3):286-289. PubMed ID: 28502480 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies. Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945 [No Abstract] [Full Text] [Related]
15. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Tan CK; Liaw SJ; Yu CJ; Teng LJ; Hsueh PR Diagn Microbiol Infect Dis; 2008 Feb; 60(2):205-10. PubMed ID: 17950557 [TBL] [Abstract][Full Text] [Related]
16. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary. Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459 [TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran. Azimi A; Rezaei F; Yaseri M; Jafari S; Rahbar M; Douraghi M Sci Rep; 2021 May; 11(1):9582. PubMed ID: 33953262 [TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing. Rizek CF; Jonas D; Garcia Paez JI; Rosa JF; Perdigão Neto LV; Martins RR; Moreno LZ; Rossi Junior A; Levin AS; Costa SF J Glob Antimicrob Resist; 2018 Dec; 15():212-214. PubMed ID: 30036694 [TBL] [Abstract][Full Text] [Related]
19. Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. Gordon NC; Wareham DW J Antimicrob Chemother; 2010 Mar; 65(3):483-9. PubMed ID: 20071366 [TBL] [Abstract][Full Text] [Related]
20. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC; J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]